Creative Medical Technology Holdings (Creative Medical Technology Holdings) Short-Term Debt & Capital Lease Obligation : $0.00 Mil (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Creative Medical Technology Holdings Short-Term Debt & Capital Lease Obligation?

Short-Term Debt & Capital Lease Obligation is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt. Creative Medical Technology Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.00 Mil.

Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. Creative Medical Technology Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.00 Mil.

Creative Medical Technology Holdings Short-Term Debt & Capital Lease Obligation Historical Data

The historical data trend for Creative Medical Technology Holdings's Short-Term Debt & Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creative Medical Technology Holdings Short-Term Debt & Capital Lease Obligation Chart

Creative Medical Technology Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt & Capital Lease Obligation

Get a 7-Day Free Trial

1.06

0.79

Creative Medical Technology Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Short-Term Debt & Capital Lease Obligation	Get a 7-Day Free Trial															-	-	-	-	-

Creative Medical Technology Holdings Short-Term Debt & Capital Lease Obligation Calculation

This is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt.

In the notes to balance sheet in annual (10-K) or quarterly (10-Q) reports, companies usually break down the details of the debt, their due dates, the interest rates etc.

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Creative Medical Technology Holdings Short-Term Debt & Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Creative Medical Technology Holdings's Short-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Creative Medical Technology Holdings (Creative Medical Technology Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Creative Medical Technology Holdings Inc (NAS:CELZ) » Definitions » Short-Term Debt & Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

211 E Osborn Road, Phoenix, AZ, USA, 85012

Website

https://www.creativemedicaltechnology.com

Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid-derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.

Executives

Timothy Warbington	director, 10 percent owner, officer: President & CEO	211 E. OSBORN ROAD, PHOENIX AZ 85012
Michael H. Finger	director	1551 N. DIANE ST., MESA AZ 85203-3850
Susan H Snow	director	26 SEDGE FERN DRIVE, HILTON HEAD SC 29926
Bruce Steven Urdang	director	5171 E. HAWTHORNE DR., FLAGSTAFF AZ 86004-7377
Thomas Ichim	director	211 E. OSBORN RD, PHOENIX AZ 85012
Creative Medical Health Inc.	10 percent owner	211 E. OSBORN RD, PHOENIX AZ 85012
Timothy Herbst	10 percent owner	2031 W. PEORIA AVE., SUITE 250, PHOENIX AZ 85029
Amit Nilkanth Patel	director	1040 CHARTWELL CT., SALT LAKE CITY UT 84121
Donald Dickerson	director, officer: CFO & Sr.VP	822 VERA STREET, SOLANA BEACH CA 92075
Steven L White	director, officer: President,Secretary,Treasurer	386 NORTH 210 EAST, MAPLETON UT 84664